# Krishna Institute of Medical Sciences (NSE: KIMS) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/KIMS · Pivot · prices to 22 Oct 2026

Krishna Institute of Medical Sciences (NSE: KIMS) closed at ₹671.30 on 22 Oct 2026, up 0.04% on the day. With a market capitalisation of ₹28,080 Cr, it ranks 286th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 111.9× trailing earnings, against a return on equity of 18.0% in FY25. Over the past year the share price has fallen 5.5%. Its 52-week range is ₹575.80 (27 Jan 2026) to ₹858.00 (6 Jul 2026); the last close is 21.8% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹1,180 Cr (+35.3% year on year) and net profit ₹36 Cr (−57.2%), on a consolidated basis. Promoters held 32.50% of the company as of 30 Jun 2026; 10.26% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹671.30 |
| Market cap | ₹28,080 Cr |
| P/E (trailing) | 111.9 |
| ROE | 18.0% (FY25) |
| ROCE | 13.0% (FY25) |
| Debt to equity | 0.89 |
| 52-week high | ₹858.00 (6 Jul 2026) |
| 52-week low | ₹575.80 (27 Jan 2026) |
| 1-year return | −5.5% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹1,180 Cr | +35.3% | ₹36 Cr | −57.2% | ₹1.04 |
| Q4 FY26 | ₹1,075 Cr | +34.8% | ₹31 Cr | −71.3% | ₹1.06 |
| Q3 FY26 | ₹998 Cr | +29.2% | ₹52 Cr | −43.9% | ₹1.33 |
| Q2 FY26 | ₹961 Cr | +23.6% | ₹72 Cr | −40.3% | ₹1.67 |
| Q1 FY26 | ₹872 Cr | +26.6% | ₹85 Cr | −10.7% | ₹1.96 |
| Q4 FY25 | ₹797 Cr | +25.7% | ₹106 Cr | +48.1% | ₹2.54 |
| Q3 FY25 | ₹772 Cr | +27.5% | ₹93 Cr | +20.6% | ₹2.22 |
| Q2 FY25 | ₹777 Cr | +19.1% | ₹121 Cr | +19.2% | ₹2.68 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹3,035 Cr | ₹404 Cr |
| FY24 | ₹2,498 Cr | ₹336 Cr |
| FY23 | ₹2,198 Cr | ₹366 Cr |
| FY22 | ₹1,651 Cr | ₹334 Cr |
| FY21 | ₹1,330 Cr | ₹205 Cr |
| FY20 | ₹1,123 Cr | ₹115 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 32.50%
- Foreign institutions: 14.74%
- Domestic institutions: 34.43%
- Non-institutions: 18.33%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Global Health](https://app.pivotnow.in/stock/MEDANTA) | ₹1,215.10 | ₹32,216 Cr | 58.9 | 14.0% |
| [Dr. Lal Path Labs](https://app.pivotnow.in/stock/LALPATHLAB) | ₹1,838.50 | ₹30,907 Cr | 58 | 20.1% |
| [Wockhardt](https://app.pivotnow.in/stock/WOCKPHARMA) | ₹1,889.60 | ₹30,150 Cr | 144.8 | 4.3% |
| [Sai Life Sciences](https://app.pivotnow.in/stock/SAILIFE) | ₹1,396.80 | ₹29,633 Cr | 85.1 | 8.0% |
| [Piramal Pharma](https://app.pivotnow.in/stock/PPLPHARMA) | ₹194.27 | ₹25,960 Cr | 25 | −4.0% |
| [Neuland Laboratories](https://app.pivotnow.in/stock/NEULANDLAB) | ₹18,855.00 | ₹24,293 Cr | 66.3 | 19.4% |

## Questions and answers

### What is the share price of Krishna Institute of Medical Sciences today?

Krishna Institute of Medical Sciences (NSE: KIMS) last closed at ₹671.30 on 22 Oct 2026. Its 52-week high is ₹858.00 and its 52-week low is ₹575.80.

### What is the market cap of Krishna Institute of Medical Sciences?

Krishna Institute of Medical Sciences' market capitalisation is ₹28,080 Cr (₹28,080 Cr) at the 22 Oct 2026 close, ranking 286th among the NSE companies Pivot tracks.

### What is the P/E ratio of Krishna Institute of Medical Sciences?

Krishna Institute of Medical Sciences trades at a trailing P/E of 111.9. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 66.3.

### What is the ROE and ROCE of Krishna Institute of Medical Sciences?

Return on equity was 18.0% in FY25 and return on capital employed was 13.0% in FY25 (consolidated figures).

### Is Krishna Institute of Medical Sciences a debt-free company?

No. Krishna Institute of Medical Sciences' debt-to-equity ratio was 0.89 in FY25, with total debt of ₹1,654 Cr.

### What were Krishna Institute of Medical Sciences' latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Krishna Institute of Medical Sciences reported revenue of ₹1,180 Cr, +35.3% year on year, and net profit of ₹36 Cr, −57.2% year on year.

### How has Krishna Institute of Medical Sciences stock performed over the last year?

Krishna Institute of Medical Sciences' share price has fallen 5.5% over the past year, −14.8% over three months and −15.0% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Krishna Institute of Medical Sciences?

As of 30 Jun 2026: promoters 32.50%, foreign institutions 14.74%, domestic institutions 34.43%, non-institutions 18.33%. 10.26% of promoter shares were pledged.

### Who are Krishna Institute of Medical Sciences' competitors?

The listed Pharma & Healthcare companies closest to Krishna Institute of Medical Sciences by market cap are Global Health, Dr. Lal Path Labs, Wockhardt, Sai Life Sciences, Piramal Pharma and Neuland Laboratories.

### Is Krishna Institute of Medical Sciences a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Krishna Institute of Medical Sciences' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KIMS against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.